MANN MICHAEL SCOTT (President) purchased 0.0% of their position (10K shares) of ENDONOVO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $275.80 — a small addition. The strongest form of insider conviction signal.
P · 5 purchases
Filed: 1/24/2019ACC: 0001645627-19-000004
Officer10% Owner· President
Since Jun 2018
+10K
Net shares
Net buyer
$275.80
Total acquired
5
Open market trades
5B · 0S
5
Total transactions
10K acquired
Non-Derivative Transactions5
Common Stock
Direct
Shares
+2K
Price / share
$0.03
Trade value
$56.60
% of position
0.0%
1/18/2019
26.69M→26.69M
Common Stock
Direct
Shares
+2K
Price / share
$0.03
Trade value
$54.80
% of position
0.0%
1/18/2019
26.69M→26.69M
Common Stock
Direct
Shares
+2K
Price / share
$0.03
Trade value
$56.80
% of position
0.0%
1/18/2019
26.69M→26.70M
Common Stock
Direct
Shares
+2K
Price / share
$0.03
Trade value
$53.80
% of position
0.0%
1/18/2019
26.70M→26.70M
Common Stock
Direct
Shares
+2K
Price / share
$0.03
Trade value
$53.80
% of position
0.0%
1/18/2019
26.70M→26.70M
Total
Net shares
+10K
Net value
$275.80
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/18/2019 | P · Purchase | +2K | $0.03 | $56.60 | 0.0% | 26.69M | 26.69M |
| Common Stock Direct | 1/18/2019 | P · Purchase | +2K | $0.03 | $54.80 | 0.0% | 26.69M | 26.69M |
| Common Stock Direct | 1/18/2019 | P · Purchase | +2K | $0.03 | $56.80 | 0.0% | 26.69M | 26.70M |
| Common Stock Direct | 1/18/2019 | P · Purchase | +2K | $0.03 | $53.80 | 0.0% | 26.70M | 26.70M |
| Common Stock Direct | 1/18/2019 | P · Purchase | +2K | $0.03 | $53.80 | 0.0% | 26.70M | 26.70M |
| Total | +10K | $275.80 | ||||||
Derivative Transactions0
No derivative transactions reported